Moreover, agents increasing the expression or activity of LPL reduce the serum levels of TC, TG, low-density lipoprotein cholesterol (LDL-C), and very low-density lipoprotein cholesterol (VLDL-C) in serum, and increase the level of HDL-cholesterol, thus reducing the incidence of hyperlipidemia and atherosclerosis [129]. Here, LPL is linked to hyperlipidemia.